瑞康医药：累计回购约2044.65万股

Group 1 - The core announcement from Ruikang Pharmaceutical indicates that the company plans to repurchase approximately 20.4465 million shares, which represents 1.36% of its total share capital, with a total transaction amount of 60.3963 million yuan [2] - The share repurchase was conducted through a centralized bidding method, with a maximum transaction price of 3.08 yuan per share and a minimum price of 2.75 yuan per share [2] - For the fiscal year 2024, Ruikang Pharmaceutical's revenue composition shows that sales of pharmaceuticals and medical devices account for 98.84%, mobile healthcare for 0.86%, and leasing for 0.3% [2]